Clifton E. Barry
← Back to Institute of Infectious Disease and Molecular Medicine
Institute of Infectious Disease and Molecular Medicine
Clifton E. Barry works in Tuberculosis Research and Epidemiology, Infectious Diseases and Tuberculosis, Mycobacterium research and diagnosis, Bacterial Genetics and Biotechnology, Microbial Natural Products and Biosynthesis. Recorded institutional associations include National Institutes of Health, University of Cape Town, National Institute of Allergy and Infectious Diseases.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
1998 · 7,827 citationsThe spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 · 1,422 citationsA small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
2000 · 1,034 citationsHost-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
2014 · 767 citationsA glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
2004 · 762 citationsTuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
2008 · 664 citationsPA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
2008 · 628 citationsThe Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
2004 · 606 citationsTuberculosis
2015 · 599 citationsVirulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
2001 · 595 citationsMycolic acids: structure, biosynthesis and physiological functions
1998 · 565 citationsLinezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
2012 · 560 citationsDeciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
1998 · 555 citationsNeutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB
2009 · 546 citationsEvolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage
2015 · 543 citationsThe salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages
2000 · 529 citationsPyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
2011 · 514 citationsSQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
2012 · 504 citationsMeropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
2009 · 494 citationsTuberculosis: What We Don’t Know Can, and Does, Hurt Us
2010 · 489 citationsThe association between sterilizing activity and drug distribution into tuberculosis lesions
2015 · 461 citationsTuberculosis — metabolism and respiration in the absence of growth
2004 · 448 citationsCompensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
1996 · 436 citationsElemental Analysis of Mycobacterium avium -, Mycobacterium tuberculosis -, and Mycobacterium smegmatis -Containing Phagosomes Indicates Pathogen-Induced Microenvironments within the Host Cell’s Endosomal System
2005 · 435 citationsDnaE2 Polymerase Contributes to In Vivo Survival and the Emergence of Drug Resistance in Mycobacterium tuberculosis
2003 · 421 citations
